Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$42.64 USD
-0.42 (-0.98%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $42.65 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Tandem Diabetes Care, Inc. (TNDM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$52.81 | $75.00 | $18.00 | 22.64% |
Price Target
Based on short-term price targets offered by 16 analysts, the average price target for Tandem Diabetes Care, Inc. comes to $52.81. The forecasts range from a low of $18.00 to a high of $75.00. The average price target represents an increase of 22.64% from the last closing price of $43.06.
Analyst Price Targets (16)
Broker Rating
Tandem Diabetes Care, Inc. currently has an average brokerage recommendation (ABR) of 1.65 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms. The current ABR compares to an ABR of 1.65 a month ago based on 17 recommendations.
Of the 17 recommendations deriving the current ABR, 12 are Strong Buy, representing 70.59% of all recommendations. A month ago, Strong Buy represented 70.59%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 12 | 11 | 11 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 2 | 2 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.65 | 1.65 | 1.65 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/8/2024 | Canaccord Genuity | William J Plovanic | Not Available | Strong Buy |
8/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/5/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
8/2/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Hold | Hold |
8/2/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
8/2/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
8/2/2024 | Raymond James | Jayson T Bedford | Hold | Hold |
8/2/2024 | UBS | Danielle Antalffy | Not Available | Hold |
8/1/2024 | SVB Securities | Michael Kratky | Strong Buy | Strong Buy |
7/7/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/30/2024 | Atlantic Equities | Issie Kirby | Not Available | Strong Buy |
5/22/2024 | Lake Street Capital Markets | Brooks G O'Neil | Strong Buy | Strong Buy |
5/22/2024 | Not Identified | Not Identified | Hold | Strong Buy |
5/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.65 |
ABR (Last week) | 1.65 |
# of Recs in ABR | 17 |
Average Target Price | $52.81 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 62 of 253 |
Current Quarter EPS Est: | -0.43 |
TNDM FAQs
Tandem Diabetes Care, Inc. (TNDM) currently has an average brokerage recommendation (ABR) of 1.65 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 17 brokerage firms.
The average price target for Tandem Diabetes Care, Inc. (TNDM) is $52.81. The current on short-term price targets is based on 9 reports.
The forecasts for Tandem Diabetes Care, Inc. (TNDM) range from a low of $18 to a high of $75. The average price target represents a increase of $23.85 from the last closing price of $42.64.
The current UPSIDE for Tandem Diabetes Care, Inc. (TNDM) is 23.85%
Based on short-term price targets offered by 16 analysts, the average price target for Tandem Diabetes Care, Inc. comes to $52.81. The forecasts range from a low of $18.00 to a high of $75.00. The average price target represents an increase of 22.64% from the last closing price of $43.06.